3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
3
Completed
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
374
Carboplatin
276
Specimen Handling
265
Nivolumab
251
Magnetic Resonance Spectroscopy
246
Cyclophosphamide
240
Cisplatin
214
Paclitaxel
205
Radiotherapy
196
Biopsy
172
Gemcitabine
155
Dexamethasone
150
durvalumab
144
atezolizumab
125
Rituximab
120
Doxorubicin
115
Bevacizumab
114
Lenalidomide
113
Ipilimumab
113
Radiation
110
Pemetrexed
101
Etoposide
101
Docetaxel
101
fludarabine
97
venetoclax
95
Capecitabine
92
Fluorouracil
91
Radiosurgery
90
Prednisone
89
Oxaliplatin
88
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Cell- and Tissue-Based Therapy
×
1 year
×
Clear all
NCT06084884
2026-05-22
ATHENA
AstraZeneca
Phase 1/2
Active not recruiting
94 enrolled